Medicure Inc. (MPH.V)
TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
At close: 11:25AM EDT
| Previous Close | 1.0000 |
| Open | 1.0200 |
| Bid | 1.0200 x 0 |
| Ask | 1.1500 x 0 |
| Day's Range | 1.0200 - 1.0200 |
| 52 Week Range | 0.9200 - 1.8000 |
| Volume | |
| Avg. Volume | 2,367 |
| Market Cap | 10.645M |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2500 |
| Earnings Date | Nov 19, 2024 - Nov 25, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.Medicure Second Quarter 2024 Earnings: CA$0.12 loss per share (vs CA$0.024 profit in 2Q 2023)
Medicure ( CVE:MPH ) Second Quarter 2024 Results Key Financial Results Revenue: CA$5.17m (down 14% from 2Q 2023). Net...
- ACCESSWIRE
Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property
WINNIPEG, MB / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...
- ACCESSWIRE
Medicure Reports Financial Results for Quarter Ended June 30, 2024
WINNIPEG, ON / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...
© 2024 Yahoo. All rights reserved.